Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Ali

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Physiological Research|November 5, 2013
Motor and behavioral changes in mice with cisplatin-induced acute renal failureB H Ali, A Ramkumar, T T Madanagopal, et al.
Physiological Research|December 20, 2019
Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damageB H Ali, S Al Salam, Y Al Suleimani, et al.
Revue D'Elevage Et De Medecine Veterinaire Des Pays Tropicaux|January 1, 1984
Infectious necrotic hepatitis (black disease) among Sudanese sheepM T Abu-Samra, S M el Sanousi, S O Idris, et al.
European Review for Medical and Pharmacological Sciences|February 22, 2013
Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent studyN Al-Kharusi, H A Babiker, S Al-Salam, et al.
American Journal of Ophthalmology|October 1, 1995
Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell lineS Logani, A S Cho, B H Ali, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study designAndrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Physiological Research|November 5, 2013
Motor and behavioral changes in mice with cisplatin-induced acute renal failureB H Ali, A Ramkumar, T T Madanagopal, et al.
Physiological Research|December 20, 2019
Ameliorative effect of sesamin in cisplatin-induced nephrotoxicity in rats by suppressing inflammation, oxidative/nitrosative stress, and cellular damageB H Ali, S Al Salam, Y Al Suleimani, et al.
Revue D'Elevage Et De Medecine Veterinaire Des Pays Tropicaux|January 1, 1984
Infectious necrotic hepatitis (black disease) among Sudanese sheepM T Abu-Samra, S M el Sanousi, S O Idris, et al.
European Review for Medical and Pharmacological Sciences|February 22, 2013
Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent studyN Al-Kharusi, H A Babiker, S Al-Salam, et al.
American Journal of Ophthalmology|October 1, 1995
Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell lineS Logani, A S Cho, B H Ali, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study designAndrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
Pageof 18